Correlation Between Kronos Bio and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Novavax, you can compare the effects of market volatilities on Kronos Bio and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Novavax.

Diversification Opportunities for Kronos Bio and Novavax

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Kronos and Novavax is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Kronos Bio i.e., Kronos Bio and Novavax go up and down completely randomly.

Pair Corralation between Kronos Bio and Novavax

Given the investment horizon of 90 days Kronos Bio is expected to under-perform the Novavax. But the stock apears to be less risky and, when comparing its historical volatility, Kronos Bio is 2.12 times less risky than Novavax. The stock trades about -0.11 of its potential returns per unit of risk. The Novavax is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  793.00  in Novavax on December 28, 2024 and sell it today you would lose (67.00) from holding Novavax or give up 8.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kronos Bio  vs.  Novavax

 Performance 
       Timeline  
Kronos Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kronos Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Novavax 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Novavax is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Kronos Bio and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kronos Bio and Novavax

The main advantage of trading using opposite Kronos Bio and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Kronos Bio and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data